E-LIB Suche - Ergebnisse für: Di Noia, Vincenzo

1

Rapid decline of humoral response to two doses of BNT162b2 ..:

Di Noia, Vincenzo ; Pimpinelli, Fulvia ; Renna, Davide...
European Journal of Cancer. 165 (2022) - p. 169-173 , 2022

Link: https://doi.org/10.1016/..

2

Duration of humoral response to the third dose of BNT162b2 ..:

Di Noia, Vincenzo ; Pimpinelli, Fulvia ; Renna, Davide...
European Journal of Cancer. 176 (2022) - p. 164-167 , 2022

Link: https://doi.org/10.1016/..

3

The first report on coronavirus disease 2019 (COVID-19) vac..:

Di Noia, Vincenzo ; Renna, Davide ; Barberi, Vittoria...
European Journal of Cancer. 153 (2021) - p. 260-264 , 2021

Link: https://doi.org/10.1016/..

4

Smoking status during first‐line immunotherapy and chemothe..:

Cortellini, Alessio ; De Giglio, Andrea ; Cannita, Katia...
Thoracic Cancer. 12 (2021) 6 - p. 880-889 , 2021

Link: https://doi.org/10.1111/..

5

Salvage radiotherapy for oligo-progressive malignant pleura..:

Ghirardelli, Paolo ; Franceschini, Davide ; D'Aveni, Alessandro...
Lung Cancer. 152 (2021) - p. 1-6 , 2021

Link: https://doi.org/10.1016/..

6

PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Pr..:

Ferrara, Miriam Grazia ; Martini, Maurizio ; D'Argento, Ettore...
Clinical Lung Cancer. 22 (2021) 4 - p. 351-360 , 2021

Link: https://doi.org/10.1016/..

7

Exploring the role of respiratory microbiome in lung cancer..:

Perrone, Fabiana ; Belluomini, Lorenzo ; Mazzotta, Marco...
Critical Reviews in Oncology/Hematology. 164 (2021) - p. 103404 , 2021

Link: https://doi.org/10.1016/..

8

Antibody Persistence 6 Months Post-Vaccination with BNT162b..:

Campo, Flaminia ; Venuti, Aldo ; Pimpinelli, Fulvia...
Vaccines. 9 (2021) 10 - p. 1125 , 2021

Link: https://doi.org/10.3390/..

9

Reply to the letter entitled: Re: The first report on Covid..:

Di Noia, Vincenzo ; Riva, Federica ; Di Civita, Mattia..
European Journal of Cancer. 158 (2021) - p. 253-254 , 2021

Link: https://doi.org/10.1016/..

10

Clinical outcomes of NSCLC patients experiencing early immu..:

Russano, Marco ; Cortellini, Alessio ; Giusti, Raffaele...
Cancer Immunology, Immunotherapy. 71 (2021) 4 - p. 865-874 , 2021

Link: https://doi.org/10.1007/..

11

Clinicopathologic correlates of first-line pembrolizumab ef..:

Cortellini, Alessio ; Tiseo, Marcello ; Banna, Giuseppe L....
Cancer Immunology, Immunotherapy. 69 (2020) 11 - p. 2209-2221 , 2020

Link: https://doi.org/10.1007/..

12

Blood serum amyloid A as potential biomarker of pembrolizum..:

Di Noia, Vincenzo ; D'Argento, Ettore ; Pilotto, Sara...
Cancer Immunology, Immunotherapy. 70 (2020) 6 - p. 1583-1592 , 2020

Link: https://doi.org/10.1007/..

13

Baseline BMI and BMI variation during first line pembrolizu..:

Cortellini, Alessio ; Ricciuti, Biagio ; Tiseo, Marcello...
Journal for ImmunoTherapy of Cancer. 8 (2020) 2 - p. e001403 , 2020

Link: https://doi.org/10.1136/..

14

Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opp..:

Ferrara, Miriam Grazia ; Di Noia, Vincenzo ; D'Argento, Ettore...
Cancers. 12 (2020) 5 - p. 1196 , 2020

Link: https://doi.org/10.3390/..

15

Immune checkpoint inhibitors in SARS-CoV-2 infected cancer ..:

Di Noia, Vincenzo ; D'Aveni, Alessandro ; Squadroni, Michela..
Lung Cancer. 145 (2020) - p. 208-210 , 2020

Link: https://doi.org/10.1016/..